drugset / Trial / NCT01577186
Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to explore the relationship between achieving symptomatic remission status by means of the 8 items of Positive and Negative Syndrome Scale (PANSS), and personal and social functioning by means of the Personal and Social Performance (PSP) scale in participants treated with flexibly dosed paliperidone ER.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paliperidone | Unknown | 3 mg | Oral |
| Subject | Paliperidone | Unknown | 12 mg | Oral |